E75.11
Mucolipidosis IV
Clinical Classification Guidelines
Medical Intelligence & Overview
Mucolipidosis IV (ML IV) is a rare inherited disorder affecting the body's ability to process and break down certain cell materials. This condition primarily impacts the nervous system and eye health, leading to developmental delays and vision problems. ML IV is categorized under the ICD-10 code E75.11, highlighting its classification as a lysosomal storage disorder.
Causes & Symptoms
Clinical Causes: Genetic mutations in the MCOLN1 gene Autosomal recessive inheritance pattern, meaning both parents must carry the gene mutation for a child to inherit the disorder Disruption in the function of the mucolipin-1 protein, which plays a crucial role in intracellular transport and cellular function
Key Symptoms: Developmental delays, including delayed motor skills and cognitive development Vision impairments, such as reduced visual acuity and loss of peripheral vision Intellectual disability of varying severity Progressive difficulty in coordination and movement Other features may include speech delays and behavioral challenges
Diagnostic & Treatment
Diagnosis Path: Blood tests to measure enzyme activity related to lysosomal function Genetic testing to identify mutations in the MCOLN1 gene Electroretinogram (ERG) and other eye examinations to assess visual function Imaging studies like MRI to evaluate neurological development
Treatment Protocols: Supportive therapies such as physical, occupational, and speech therapy to enhance developmental skills Vision correction tools and supportive measures to address visual impairments Regular monitoring of neurological and physical development Educational accommodations tailored to individual learning needs Participation in clinical trials and research studies exploring potential therapies
Clinical Advice & FAQs
Billing Guidance
Is E75.11 a billable ICD-10 code?
Yes, E75.11 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E75.11?
Clinical documentation must specify the nature of Mucolipidosis IV and any associated comorbidities for accurate reporting.
Cite this Clinical Reference